Výsledky vyhledávání

Akademický článek

Strategic discussion on funding and access to therapies targeting rare diseases in Spain: an expert consensus paper.

Autor: Zozaya, N.¹ (AUTHOR) neboa.zozaya@weber.org.es, Villaseca, J.¹ (AUTHOR), Abdalla, F.¹ (AUTHOR), Ancochea, A.² (AUTHOR), Málaga, I.³ (AUTHOR), Trapero-Bertran, M.⁴ (AUTHOR), Martín-Sobrino, N.⁵ (AUTHOR), Delgado, O.⁶ (AUTHOR), Ferré, P.⁷ (AUTHOR), Hidalgo-Vega, A.⁸ (AUTHOR)

Publikováno v: Orphanet Journal of Rare Diseases. 2/24/2023, p1-14. 14p.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis

Autor: Zozaya, N, Abdalla, F, Zamora, SA, Filgueiras, JB, Carrillo, JMC, Sanchez, OD, Sinisterra, FD, Garcia-Ruiz, A, Pinto, PH, Manfredi, A, Olmos, JM, Luna, PMD, Puig, L, Ros, S, HIdalgo-Vega, A

Publikováno v: Expert Review of Pharmacoeconomics & Outcomes Research
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol

Background Multi-criteria decision analysis (MCDA) was proposed to surmount arbitrary clinical decisions in the field of biological therapies for psoriatic patients. At the same time, MCDA may further highlight the potential of bimekizumab for the tr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b65758666c876340724156dce517ad35
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=9913

Zobrazit plný text záznamu

A strategic reflection for the management and implementation of CAR-T therapy in Spain: an expert consensus paper

Autor: Zozaya, N, Villaseca, J, Abdalla, F, Calleja, MA, Diez-Martin, JL, Estevez, J, Garcia-Sanz, R, Martinez-Lopez, J, Sierra, J, Vera, R, Hidalgo-Vega, A

Publikováno v: Clinical & Translational Oncology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

CAR-T cell therapy represents a therapeutic revolution in the prognosis and treatment of patients with certain types of hematological cancer. However, they also pose new challenges in the healthcare, regulatory and financial fields. The aim of the RE

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::af8553f42653c8fcb01541b665405272
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6263

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání